Call for Papers  

Article Details


Research Article

The Absence of Myelin Basic Protein Reduces Non-Amyloidogenic Processing of Amyloid Precursor Protein

[ Vol. 18 , Issue. 4 ]

Author(s):

Chika Seiwa*, Ichiro Sugiyama , Makoto Sugawa, Hiroaki Murase , Chiaki Kudoh and Hiroaki Asou   Pages 326 - 334 ( 9 )

Abstract:


<P>Background: The accumulation of amyloid &#946;-protein (A&#946;) in the brain is a pathological feature of Alzheimer’s disease (AD). A&#946; peptides originate from amyloid precursor protein (APP). APP can be proteolytically cleaved through amyloidogenic or non-amyloidogenic pathways. The molecular effects on APP metabolism/processing may be influenced by myelin and the breakdown of myelin basic protein (MBP) in AD patients and mouse models of AD pathology. </P><P> Methods: We directly tested whether MBP can alter influence APP processing in MBP-/- mice, known as Shiverer (shi/shi) mice, in which no functional MBP is produced due to gene breakage from the middle of MBP exon ll. </P><P> Results: A significant reduction of the cerebral sAPP&#945; level in Shiverer (shi/shi) mice was found, although the levels of both total APP and sAPP&#946; remain unchanged. The reduction of sAPP&#945; was considered to be due to the changes in the expression levels of a disintegrin and metalloproteinase-9 (ADAM9) catalysis and non-amyloid genic processing of APP in the absence of MBP because it binds to ADAM9. MBP -/- mice exhibited increased A&#946; oligomer production. </P><P> Conclusion: These findings suggest that in the absence of MBP, there is a marked reduction of nonamyloidogenic APP processing to sAPP&#945;, and targeting myelin of oligodendrocytes may be a novel therapy for the prevention and treatment of AD.</P>

Keywords:

Alzheimer&#39;s disease (AD), myelin basic protein (MBP), amyloid precursor protein (APP), myelination, soluble App &#945; (sAPP&#945;), non amyloidogenic processing.

Affiliation:

Center for Kampo Medicine, Keio University School of Medicine, Shinanomachi, Shinjukuku, Tokyo 160-8582, Department of Neurosurgy, Keio University School of Medicine, Shinanomachi, Shinjukuku, Tokyo 160-8582, Center for Kampo Medicine, Keio University School of Medicine, Shinanomachi, Shinjukuku, Tokyo 160-8582, Glovia Myelin Research Institute, 75-1, Onocho, Tsurumi-ku, Yokohama, Kanagawa 230-0046, KUDOH Clinic for Neurosurgery and Neurology, 1-23-10, Omori-kita, Otaku, Tokyo 143-0016, Center for Kampo Medicine, Keio University School of Medicine, Shinanomachi, Shinjukuku, Tokyo 160-8582



Read Full-Text article